eNauka - pregled

Pregled prema Autor Young, James

Prikaz rezultata 1 do 9 od 9
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2021Cardiovascular outcomes associated with achieved haemoglobin level and preliminary rate of rise of haemoglobin in pooled phase 3 studies of roxadustat in non-dialysis-dependent patients with anaemiaBarratt, Jonathan; Sulowicz, Wladyslaw; Cockburn, Elinor; Reusch, Michael; Young, James; Dimkovic, Nada BKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2021Cardiovascular Outcomes Associated with Achieved Haemoglobin Level in Pooled Phase 3 Studies of Roxadustat in Non-Dialysis-Dependent Patients with AnaemiaBarratt, Jonathan; Sulowicz, Wladyslaw; Cockburn, Elinor; Reusch, Michael; Young, James; Dimkovic, Nada BKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2022Cardiovascular Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents for Treatment of Anemia in Patients With Chronic Kidney Disease Incident to or Not Receiving Dialysis: Pooled Subgroup Analysis of Four Phase 3 StudiesEsposito, Ciro; Barratt, Jonathan; Dellanna, Frank; Portoles, Jose; Choukroun, Gabriel; De, Nicola Luca; Reusch, Michael; Young, James; Jiletcovici, Alina; Dimkovic, Nada BKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2022Iron Parameters in Patients Treated With Roxadustat for Anemia Associated With Chronic Kidney Disease: Post Hoc Analysis of the Non-Dialysis-Dependent or Incident Dialysis Population From Four Phase 3 StudiesEsposito, Ciro; Barratt, Jonathan; Dellanna, Frank; Portoles, Jose; Choukroun, Gabriel; De, Nicola Luca; Reusch, Michael; Young, James; Jiletcovici, Alina; Dimkovic, Nada BKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2021Pooled Efficacy and Cardiovascular Safety Results of 3 Placebo-Controlled and 1 Darbepoetin Alfa-Controlled Studies of Roxadustat for Treatment of Anaemia in Patients with Non-Dialysis-Dependent Chronic Kidney DiseaseBarratt, Jonathan; Dimkovic, Nada B; Shutov, Evgeny; Sulowicz, Wladyslaw; Esposito, Ciro; Reusch, Michael; Young, James; Mariat, ChristopheKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2021Pooled efficacy and cardiovascular safety results of roxadustat compared with placebo/ darbepoetin alfa for treatment of anaemia in patients with non-dialysis-dependent (NDD) chronic kidney disease (CKD)Barratt, Jonathan; Dimkovic, Nada B; Shutov, Evgeny; Sulowicz, Wladyslaw; Esposito, Ciro; Reusch, Michael; Young, James; Mariat, ChristopheKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2021Regional Efficacy and Safety Results of Roxadustat Compared with Placebo Or Darbepoetin Alfa in Non-Dialysis-Dependent (Ndd) Chronic Kidney Disease (Ckd) Patients with AnaemiaDimkovic, Nada B; Esposito, Ciro; Barratt, Jonathan; Mariat, Christophe; Shutov, Evgeny; Reusch, Michael; Young, James; Sulowicz, WladyslawKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2022Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents for Treatment of Anemia in Patients with Chronic Kidney Disease Incident to Or Not Receiving Dialysis: Pooled Analysis of Four Phase 3 StudiesBarratt, Jonathan; Dellanna, Frank; Portoles, Jose; Choukroun, Gabriel; De, Nicola Luca; Reusch, Michael; Young, James; Dimkovic, Nada BKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2023Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 StudiesBarratt, Jonathan; Dellanna, Frank; Portoles, Jose; Choukroun, Gabriel; De, Nicola Luca; Young, James; Dimkovic, Nada B; Reusch, MichaelNaučni članak
21M21 - Vodeći međunarodni časopis kategorije M21